Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Maor Investments is a Luxembourg-based venture capital investor focused on growth-stage Israeli technology companies that already generate revenue and have established proof of concept. Founded in 2017, the firm positions itself as a bridge between Israeli startups and European corporates, investors, customers, and distribution channels. Its portfolio spans enterprise software, cybersecurity, healthcare IT, fintech, agtech, and other technology sectors rather than therapeutics or drug development. Maor is therefore not a biotech, pharma, or healthcare operating company, although it has invested in some health-related technology businesses such as digital health and healthcare cybersecurity companies. The firm appears active and privately held, with operating presence in Luxembourg and Israel.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Maor Investments.